• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在格兰扁地区早期茴香酰化纤溶酶原激活剂试验(GREAT)中,家庭溶栓治疗使1年死亡率减半。

Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).

作者信息

Rawles J

机构信息

Medicines Assessment Research Unit, University of Aberdeen, Scotland, United Kingdom.

出版信息

J Am Coll Cardiol. 1994 Jan;23(1):1-5. doi: 10.1016/0735-1097(94)90494-4.

DOI:10.1016/0735-1097(94)90494-4
PMID:8277066
Abstract

OBJECTIVES

Our aim was to determine the time saved by administration of thrombolytic therapy at home rather than in the hospital and to assess whether earlier thrombolysis resulted in decreased mortality from acute myocardial infarction.

BACKGROUND

There is much theoretic, experimental and trial evidence to indicate that in acute myocardial infarction the earlier that thrombolytic therapy is given, the greater its efficacy. However, the clinical importance of this time effect is uncertain.

METHODS

In a randomized double-blind parallel-group clinical trial, 311 patients with suspected acute myocardial infarction seen by their general practitioners within 4 h of symptom onset were given intravenous anistreplase (30 U) either at home or later, after arrival in the hospital.

RESULTS

Anistreplase was given at home or in the hospital at median times of 101 and 240 min, respectively, after symptom onset. The median time saved by domiciliary thrombolysis was 130 min. By the end of 1 year after trial entry, 17 (10.4%) of 163 patients given anistreplase at home died compared with 32 (21.6%) of 148 in those allotted anistreplase in the hospital (relative reduction 52%, 95% confidence interval 14% to 89%, p = 0.007).

CONCLUSIONS

In this trial the time saved by domiciliary thrombolysis by primary care physicians was > 2 h. It is likely that a similar time saving would be achieved if prehospital thrombolysis were to become established practice. Prehospital thrombolysis resulted in a halving of the mortality rate from acute myocardial infarction.

摘要

目的

我们的目的是确定在家而非在医院进行溶栓治疗所节省的时间,并评估早期溶栓是否能降低急性心肌梗死的死亡率。

背景

有大量理论、实验和试验证据表明,在急性心肌梗死中,溶栓治疗给予得越早,其疗效越好。然而,这种时间效应的临床重要性尚不确定。

方法

在一项随机双盲平行组临床试验中,311例症状发作后4小时内被全科医生诊治的疑似急性心肌梗死患者,在家中或到达医院后接受静脉注射茴酰化纤溶酶原链激酶激活剂复合物(30U)。

结果

症状发作后,在家中和医院给予茴酰化纤溶酶原链激酶激活剂复合物的中位时间分别为101分钟和240分钟。家庭溶栓节省的中位时间为130分钟。试验入组1年后,在家中接受茴酰化纤溶酶原链激酶激活剂复合物治疗的163例患者中有17例(10.4%)死亡,而在医院接受该治疗的148例中有32例(21.6%)死亡(相对降低52%,95%置信区间14%至89%,p = 0.007)。

结论

在本试验中,初级保健医生进行家庭溶栓节省的时间超过2小时。如果院前溶栓成为既定做法,可能会节省类似的时间。院前溶栓使急性心肌梗死的死亡率减半。

相似文献

1
Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).在格兰扁地区早期茴香酰化纤溶酶原激活剂试验(GREAT)中,家庭溶栓治疗使1年死亡率减半。
J Am Coll Cardiol. 1994 Jan;23(1):1-5. doi: 10.1016/0735-1097(94)90494-4.
2
Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.全科医生进行家庭溶栓治疗的可行性、安全性及有效性:格兰扁地区早期茴香酰化纤溶酶原链激酶激活剂复合物试验。GREAT研究小组
BMJ. 1992 Sep 5;305(6853):548-53. doi: 10.1136/bmj.305.6853.548.
3
Recovery of left ventricular function after acute myocardial infarction: efficacy of domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial.
Coron Artery Dis. 1993 Sep;4(9):801-8. doi: 10.1097/00019501-199309000-00007.
4
Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT).早期溶栓治疗获益的量化评估:格兰扁地区早期茴酰化纤溶酶原链激酶激活剂复合物试验(GREAT)的五年结果
J Am Coll Cardiol. 1997 Nov 1;30(5):1181-6. doi: 10.1016/s0735-1097(97)00299-4.
5
Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT).急性心肌梗死早期溶栓治疗的获益程度:格兰扁地区早期茴酰化纤溶酶原链激酶激活剂复合物试验(GREAT)的新证据。
BMJ. 1996 Jan 27;312(7025):212-5. doi: 10.1136/bmj.312.7025.212.
6
Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian.格兰扁地区基层医疗机构全科医生对院前溶栓治疗的审计。
Heart. 1998 Sep;80(3):231-4. doi: 10.1136/hrt.80.3.231.
7
Loss of quality adjusted days as a trial endpoint: effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT).以质量调整生命天数的损失作为试验终点:早期溶栓治疗对疑似心肌梗死的影响。格兰扁地区早期茴酰化纤溶酶原链激酶激活剂复合物试验(GREAT)。
J Epidemiol Community Health. 1993 Oct;47(5):377-81. doi: 10.1136/jech.47.5.377.
8
An economic evaluation of thrombolysis in a remote rural community.偏远农村社区溶栓治疗的经济学评估。
BMJ. 1997 Feb 22;314(7080):570-2. doi: 10.1136/bmj.314.7080.570.
9
Electrocardiographic evidence of reperfusion occurring before hospital admission. A Grampian Region Early Anistreplase Trial (GREAT) sub-study.
Eur Heart J. 1994 Jul;15(7):895-7. doi: 10.1093/oxfordjournals.eurheartj.a060607.
10
Impact of resuscitation and thrombolysis on mortality rate from acute myocardial infarction.复苏和溶栓治疗对急性心肌梗死死亡率的影响。
Int J Cardiol. 1995 Mar 24;49(1):33-7. doi: 10.1016/0167-5273(95)02271-w.

引用本文的文献

1
Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction.ST段抬高型心肌梗死的院前溶栓与院内溶栓对比
Cochrane Database Syst Rev. 2014 Sep 10;2014(9):CD010191. doi: 10.1002/14651858.CD010191.pub2.
2
Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry.绕过急诊室可减少ST段抬高型心肌梗死的延误和死亡率:美国介入心脏病学会2000年注册研究
Heart. 2006 Oct;92(10):1378-83. doi: 10.1136/hrt.2006.101972. Epub 2006 Aug 16.
3
Paramedics and pre-hospital management of acute myocardial infarction: diagnosis and reperfusion.
护理人员与急性心肌梗死的院前管理:诊断与再灌注
Emerg Med J. 2006 May;23(5):331-4. doi: 10.1136/emj.2005.028118.
4
[Acute coronary syndrome in the prehospital phase].[院前阶段的急性冠状动脉综合征]
Anaesthesist. 2005 Oct;54(10):957-74. doi: 10.1007/s00101-005-0897-z.
5
Thrombolytic therapy for myocardial infarction facilitated by mobile coronary care.移动冠状动脉护理辅助下的心肌梗死溶栓治疗。
Ulster Med J. 2004 Nov;73(2):77-84.
6
The costs and benefits of community thrombolysis for acute myocardial infarction : a decision-analytic model.急性心肌梗死社区溶栓治疗的成本与效益:一项决策分析模型
Pharmacoeconomics. 2004;22(14):943-54. doi: 10.2165/00019053-200422140-00004.
7
[Thrombolysis in ST-elevation myocardial infarction. Current role in the light of recent studies].[ST段抬高型心肌梗死的溶栓治疗。基于近期研究的当前作用]
Anaesthesist. 2004 May;53(5):445-54. doi: 10.1007/s00101-004-0678-0.
8
GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis.GREAT研究:院前溶栓与院内溶栓随机对照研究中疑似急性心肌梗死患者的10年生存率
Heart. 2003 May;89(5):563-4. doi: 10.1136/heart.89.5.563.
9
Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis.再灌注后急性ST段抬高型心肌梗死的再梗死:发生率、患者特征及预后
Heart. 2003 May;89(5):496-501. doi: 10.1136/heart.89.5.496.
10
Emergency department overcrowding and ambulance transport delays for patients with chest pain.急诊科拥挤以及胸痛患者的救护车转运延误
CMAJ. 2003 Feb 4;168(3):277-83.